Cancer Biopsy Market to Grow at an Impressive CAGR During the Forecast Period
Research and
development growth to drive the growth of Global Cancer Biopsy Market, in the
forecast period, 2022-2026.
According to TechSci
Research report, “Global Cancer Biopsy Market By Product
(Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue
Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By
Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer,
Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference
Laboratories, Hospitals and Physician Laboratories, Academic and Research
Centers), By Region, Competition Forecast & Opportunities, 2026”, the global cancer
biopsy market is projected to show a robust growth in the forecast period from
2022 to 2026. The market growth can be attributed to the surge in the demand of
early and efficient diagnostic of the various types of cancerous diseases that
are prevailing, thus it is influencing the global cancer biopsy market, as
biopsy is one of the diagnostic procedures for the cancerous cells. Moreover,
technologically advanced medical devices are being developed that have been
quite handful in the categorization of the cancer. Along with the diagnosis of
the malignancy, these devices are also actively responsible in identifying the
histology of the cancer as well as staging of the cancer thereby understanding
the level of risk the patient is at. These advents are actively driving the
growth of the global cancer biopsy market in the next five years until 2026.
Cancer is a chronic
disorder that can be defined as the mass of unregulated cell growth that take
place in a form of lump. They do not perform the set of functions they are
expected to perform and rather multiply immaturely causing bumps and mass of
cells that clutter at a single place. These clusters of cancerous cells may
grow due to various reasons like, genetic abnormalities, environmental factors,
virulent vectors or due to excessive exposure to various harmful radiations.
Some chemical factors like poisonous chemical exposure may trigger the cancer
causing genes and there by cause cancer. Cancer biopsy is a method of scoping
and dissecting a piece of cancerous mass from the cancer affected area of the
body and retrieving it for the further processes like diagnosis or research,
etc. The recent trend has seen a shift in the method of biopsy, instead of
tumor biopsy, experts are choosing liquid biopsy. Liquid biopsy is the sampling
and analysis of non-solid biological tissue, preferably blood. This method is
non-invasive and has provision of early diagnosis through screening and
determines the risk of relapse of cancer after treatment. With the presence of
biomarkers it can be beneficial in determining the best treatment plan as well
as aids the research towards mechanism of resistance, disease progression, and
identification of newer treatments.
Browse over XX market data Figures
spread through 110 Pages and an in-depth TOC on "Global
Cancer Biopsy Market"
https://www.techsciresearch.com/report/cancer-biopsy-market/7399.html
The
global cancer biopsy market is segmented on the basis of product,
type of biopsy, application, end user, competitive landscape, and regional
distribution. Based on type of biopsy the market is further bifurcated into tissue
biopsies, liquid biopsies, and others. Liquid biopsies are anticipated to hold
the largest market share owing to the increased demand for non-invasive method
of diagnosis and research sampling procedures. Liquid biopsies require kits and
consumable that are products required for the cancer biopsies which is
co-dependently driving the market growth in the forecast period, until 2026.
Tissue biopsies are sub-categorized into needle and surgical biopsies. Tissue
biopsies are also expected to hold significant share of the market owing to the
need of surgical graft of the tissues that are solid or if the cancer cells are
not available in the blood. In certain cases, like breast cancer experts have
to perform a surgical biopsy to reach the endothermal cells, or sometime needle
biopsy is used in throat cancer. Increasing instances of these cancers is
driving the growth of the market towards and is expected to continue in the
forecast period as well.
Needle biopsies are the most
popular choice among the experts owing to the efficiency, shorter wait time for
the results (with fine needle aspiration, FNA type needle biopsies). Although
various techniques demand surgical incisions like staging splenectomy for
Hodgkin’s lymphoma patients. To perform these procedures with 100% efficiency
the experts require right biopsy type for the right patients, appropriate
sample processing, and accurate pathological examination, which is driving the
market growth in the next five years.
Some
of the major competitors in the market are Qiagen N.V., Illumina, Inc., ANGLE
Plc, Becton, Dickinson and Company, Myriad Genetics Inc., Hologic, Inc., Biocept,
Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, F. Hoffmann-La Roche
Ltd., Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health Inc., Exact
Sciences Corporation, Freenome Holdings, Inc., among others. Other strategies
include forming partnerships among the market players and the research
institutions, and technological advanced products and services launches in the
forecast period.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7399
Customers can also request for 10% free
customization on this report.
“Image guided biopsies, and related technological advancements are in
trend in the market. Through a recent study, multi-parametric MRI was confirmed
to minimize the false-negative results thereby enhancing the risk assessment.
North American region is anticipated to hold the largest market share owing to
the excellent healthcare industry that is well established along with the
United States Food and Drug Administration approved procedures that increased
value for the Clinical Laboratory Improvement Amendment (CLIA)‐developed tests,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“Global Cancer Biopsy
Market By Product (Instruments, Kits and Consumables, Services), By Type of
Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies,
Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer,
Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User
(Reference Laboratories, Hospitals and Physician Laboratories, Academic and
Research Centers), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential
of global cancer biopsy market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in global cancer
biopsy.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/